NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers - Wikidata - awgldk - TriplyDB

NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers

NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers

http://www.wikidata.org/entity/Q26863349

about

Inflammation in Chronic Wounds Poly I:C induces collective migration of HaCaT keratinocytes via IL-8.Angiotensin-(1-7): A Novel Peptide to Treat Hypertension and Nephropathy in Diabetes?New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?Future drug discovery in renin-angiotensin-aldosterone system intervention.Discontinued drug therapies to treat diabetes in 2015.

P2860

Q28075962-5211D042-B23E-45D4-A6AF-34D4A30D3EBF Q33601201-3BE13692-FBEF-44E5-B61D-DBCD2749588E Q36473779-0F2DF276-4532-46BC-801F-96BDA88807C1 Q37347190-DE224195-2621-43E8-A0F2-0114A010920C Q38679303-9361A624-4056-40BA-86EB-FE197840536E Q51327624-4C6BA952-6DA4-46E4-8C9F-CE9BE2E536C0

P2860

NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers

http://www.wikidata.org/entity/Q26863349

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers

@ast

NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers

@en

NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers

@nl

type

label

NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers

@ast

NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers

@en

NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers

@nl

prefLabel

NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers

@ast

NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers

@en

NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers

@nl

P1433

Q26863349-44806F96-940C-480D-9813-E8449B611652

P1476

Q26863349-BAB5622F-F6F9-4BC0-B188-2EDE230DD233

P2093

Q26863349-19221D16-7FC2-40D5-A206-7D98ACA6EA3F

Q26863349-3B7636D0-E50B-45FC-84C0-7BAB84C95B19

Q26863349-4C98169B-8C63-4F72-BE95-315E2401402C

Q26863349-7CB72BCB-2759-4EA1-8262-445FFB60BFA1

P2860

Q26863349-0A05FC00-93FE-4A88-A59A-69E5D3FFFD54

Q26863349-117A5841-E49C-4894-A736-95F62F8B6F68

Q26863349-11F89A7A-E5F5-40B4-B1A7-CB02931195A6

Q26863349-1523EA69-1DB0-4946-BAAC-A4B6C0C11555

Q26863349-16542542-5D21-4FF2-9A93-0413AD22C7C3

Q26863349-169A39CB-3C87-44FC-BC5E-9944B5E39951

Q26863349-16CEEF8B-300D-409F-ADBC-E97D119BFCD7

Q26863349-1FD43FF0-8070-48EF-9CE4-21F770F99788

Q26863349-2B6B0C01-3DDD-4EFD-90EB-45B5086BF043

Q26863349-2EC1B10E-063E-4DF4-85D9-E70A84877A86

P304

Q26863349-2A7735BC-3F07-4428-8FFA-1EEBCBE32058

P31

Q26863349-0F0CCD98-83F8-4E8C-B38E-4139E779E510

P356

Q26863349-EE107D35-6521-45D1-991C-EF226F91D53D

P433

Q26863349-DBF11A30-A863-4BCF-96A5-ECE559EC55F1

P478

Q26863349-D86B2A9B-64B9-4B3E-BC1E-092D56D65ABF

P577

Q26863349-B853F0C8-7138-4BAD-906D-D13F32FB7D39

P698

Q26863349-FD49017E-D046-4F31-A320-AED0944B0494

P932

Q26863349-D9A1DADD-A080-4A4D-99E5-231096BF184C

P356

WOUND.2014.0609

P1433

Advances in wound care

P1476

NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers

@en

P2093

Gere S. diZerega

http://www.w3.org/2001/XMLSchema#string

Kathleen E. Rodgers

http://www.w3.org/2001/XMLSchema#string

Laura L. Bolton

http://www.w3.org/2001/XMLSchema#string

Shelagh Verco

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts. American Diabetes Association.

Reactions to amputation: recognition and treatment.

The global burden of diabetic foot disease.

Effects of combined radiation and burn injury on the renin-angiotensin system.

Angiotensin II stimulates proliferation of normal early erythroid progenitors.

Effect of angiotensin II on hematopoietic progenitor cell proliferation.

Histological evaluation of the effects of angiotensin peptides on wound repair in diabetic mice.

NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial.

Effect of angiotensin II and angiotensin(1-7) on hematopoietic recovery after intravenous chemotherapy.

Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice.

P304

339-345

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/WOUND.2014.0609

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26029484

http://www.w3.org/2001/XMLSchema#string

P932

4440979

http://www.w3.org/2001/XMLSchema#string